Irma, AstraZeneca gives FTSE a leg-up
Reuters
Published Sep 11, 2017 18:00
Irma, AstraZeneca gives FTSE a leg-up
By Kit Rees
LONDON (Reuters) - Britain's top share index closed higher on Monday, boosted by financial stocks which surfed an insurance rally across Europe and the United States as estimates of the cost of Hurricane Irma dropped.
The blue chip FTSE 100 (FTSE) index was up 0.6 percent at 7,413.59 points, while mid caps (FTMC) gained 0.4 percent.
The FTSE 350 non-life insurance index (FTNMX8530) jumped 2.1 percent, leaving it on track for its biggest one-day gain since April, with shares in Lancashire Holdings (L:LRE), Beazley (L:BEZG), Esure (L:ESUR) and Hiscox (L:HSX) all rising between 2.9 percent to 10.3 percent.
Provident (L:PFG) was the top gainer with a 3.8 percent rise as other British financial shares rose in line with Europe and Wall Street after Hurricane Irma weakened to a Category 1 storm.
"Insured losses (overall) are now expected to be less than many feared," Credit Suisse (SIX:CSGN) analysts said after the estimated insured loss in the United States resulting from Irma was cut to $20-40 billion.
In other sectors, AstraZeneca's shares were among the biggest gainers on the FTSE, rising 2.1 percent after reassuring results from two of its lung cancer drugs.
The pharma firm's shares are yet to recover from a 15 percent plunge in July, when initial results from its advanced lung cancer study, known as Mystic, failed.
"(AstraZeneca) now has a good chance of growing the opportunity from what was previously expected in Stage III lung cancer," analysts at Liberum said in a note.
"If the reaction moves much beyond this, the shares would be starting once again to price a chance of success for Mystic," they added.
Among fallers, precious metals miners Fresnillo (L:FRES) and Randgold Resources (L:RRS) were on the back foot as the price of safe-haven gold fell, while shares in Primark-owner Associated British Foods (L:ABF) were the biggest FTSE decliners, down 5 percent after giving a full-year trading update.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.